跳至主要内容
临床试验/NCT03188770
NCT03188770已完成不适用

PRactice of VENTilation in Critically Ill Patients in Middle-Income Countries (PRoVENT-iMIC) - an International Multicenter Service Review Focusing on ICUs in Asia

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)51 个研究点 分布在 10 个国家目标入组 1,315 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,315
试验地点
51
主要终点
Tidal volume size

研究概览

简要总结

The purpose of this international, multicenter service review is to describe and compare ventilation management in patients at risk of acute respiratory distress syndrome (ARDS) versus patients not at risk and patients with established ARDS, and to ascertain whether certain ventilator settings and ventilation parameters are associated with pulmonary complications or development of ARDS after start of ventilation in patients in intensive care units (ICUs) in Asian countries.

Participating centers will include adult patients undergoing mechanical ventilation in the ICU during a 28-day period. Patients' data will be collected during the first 7 days in the ICU, or until ICU discharge. Follow up is until ICU discharge. The primary outcome includes two main ventilator settings, i.e., tidal volume and the level of positive end-expiratory pressure. Secondary endpoints are development of ARDS in patients without ARDS at the onset of mechanical ventilation, worsening of ARDS in patients with ARDS at the onset of mechanical ventilation, pulmonary infection, other pulmonary complications, need for tracheostomy, duration of ventilation, length of ICU stay and ICU mortality.

详细描述

Rationale: scarce information exists on management of mechanical ventilation in intensive care unit (ICU) patients in low- and middle-income countries.

Objective:The primary objective is to describe and compare ventilation management in patients at risk of ARDS versus individuals not at risk, and patients with established ARDS, and to ascertain whether certain ventilation settings are associated with a higher incidence of developing ARDS in patients in ICUs in Asia. PRoVENT-iMIC secondary objectives are to determine the epidemiological characteristics and clinical outcomes of patients at risk of ARDS in ICUs in Asia according to the ventilation practice applied.

Primary hypothesis: a large proportion of patients at risk of ARDS in ICUs in Asia do not receive so-called protective ventilation, defined as tidal volume < 8 ml/kg predicted body weight and a level of positive end-expiratory pressure of at least 5 cm H2O.

Secondary hypothesis: in ICUs in Asia a large proportion of patients is at risk of ARDS, as stratified by a Lung Injury Prediction Score of ≥4.

Study design: an international multicenter service review focusing on ICUs in selected middle-income Asian countries.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admitted to an ICU participating in this study
  • Intubated in the ICU, or in the emergency room, general ward, or operation room before the present ICU admission

排除标准

  • Age < 18 years
  • Patients under invasive mechanical ventilation previous to the 28-day period of inclusion
  • Patients transferred from another hospital under invasive mechanical ventilation
  • Receiving only non-invasive ventilation (i.e., patient never received invasive ventilation during the present admission)

结局指标

主要结局

Tidal volume size

时间窗: Day 1 to Day 3 from initiation of mechanical ventilation

Tidal volume size in milliliters per kilogram of predicted body weight

Positive end-expiratory pressure

时间窗: Day 1 to Day 3 from initiation of mechanical ventilation

Pressure in cm of water

次要结局

  • Inspired Oxygen Concentration(Day 1 to Day 3 from initiation of mechanical ventilation)
  • Peak pressure(Day 1 to Day 3 from initiation of mechanical ventilation)
  • Driving pressure(Day 1 to Day 3 from initiation of mechanical ventilation)
  • Patients at risk of ARDS(On the date of inclusion)
  • Length of stay in ICU(Until day 35 from study initiation)
  • Plateau pressure(Day 1 to Day 3 from initiation of mechanical ventilation)
  • Development of ARDS(From date of inclusion until the date of first documented development of ARDS or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days)
  • Respiratory Rate(Day 1 to Day 3 from initiation of mechanical ventilation)
  • Pulmonary infection(From date of inclusion until the date of first documented pulmonary complication or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days)
  • Minute Volume(Day 1 to Day 3 from initiation of mechanical ventilation)
  • Other Pulmonary complications(From date of inclusion until the date of first documented pulmonary complication or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days)
  • Worsening of ARDS(From date of inclusion until the date of first documented worsening of ARDS or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days)
  • Need for tracheostomy(From date of inclusion until the date of first documented tracheostomy procedure or date of ICU discharge or death from any cause, whichever came first, assessed up to 7 days)
  • All-cause ICU mortality(Until day 35 from study initiation)
  • Duration of mechanical ventilation(Until day 35 from study initiation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Marcus J. Schultz

Prof.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

研究点 (51)

Loading locations...

相似试验